Form 485BXT Brighthouse Life Insuran
As filed with the Securities and Exchange Commission on April 2,
2026
Registration Statement File No. 333-283023
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-4
| REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 |
|
| Pre-Effective Amendment No. |
☐ |
| Post-Effective Amendment No. 5 |
☒ |
(Check Appropriate Box or Boxes)
Brighthouse Life Insurance Company
(Name of Insurance Company)
11225 North Community House Road
Charlotte, NC 28277
(Address of Insurance Company's Principal Executive Offices) (Zip Code)
Charlotte, NC 28277
(Address of Insurance Company's Principal Executive Offices) (Zip Code)
(980) 365-7100
(Insurance Company's Telephone Number, including Area Code)
Brighthouse Life Insurance Company
c/o The Corporation Trust Company
1209 Orange Street
Corporation Trust Center
New Castle County
Wilmington, DE 19801
(800) 448-5350
(Name and Address of Agent for Service)
(Insurance Company's Telephone Number, including Area Code)
Brighthouse Life Insurance Company
c/o The Corporation Trust Company
1209 Orange Street
Corporation Trust Center
New Castle County
Wilmington, DE 19801
(800) 448-5350
(Name and Address of Agent for Service)
Copies to:
W. Thomas Conner
Carlton Fields
1625 Eye Street, NW
Suite 800
Washington, DC 20006
Carlton Fields
1625 Eye Street, NW
Suite 800
Washington, DC 20006
Approximate Date of Proposed Public Offering: On April 28, 2025 or as soon
thereafter as practicable.
It is proposed that this filing will become effective (check appropriate box):
☐
immediately upon filing pursuant to paragraph (b)
☒
on
April 27, 2026 pursuant to paragraph (b)
☐
60 days after filing pursuant to paragraph (a)(1)
☐
on
(date) pursuant to paragraph (a)(1) of rule 485 under the Securities Act of 1933
(“Securities Act”).
If appropriate, check the following box:
☒
This post-effective amendment designates a new effective date for a previously filed
post-effective amendment.
Check each box that appropriately characterizes the Registrant:
☐
New Registrant (as applicable, a Registered Separate Account or Insurance Company that
has not filed a Separate Account or Insurance Company that has not filed a Securities Act registration statement or amendment thereto within 3 years preceding this filing)
☐
Emerging Growth Company (as defined by Rule 12b-2 under the Securities Exchange Act of
1934 (“Exchange Act”))
☐
If an Emerging Growth Company, indicate by check mark if the Registrant has elected not
to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act
☐
Insurance Company relying on Rule 12h-7 under the Exchange Act
☐
Smaller reporting company (as defined by Rule 12b-2 under the Exchange Act)
This Post-Effective
Amendment is being filed pursuant to rule 485(b)(1)(iii) under the Securities Act of 1933, as amended, for the sole purpose of delaying the effective date of
Post-Effective Amendment No.2 (“Amendment No. 2”) to Registration Statement File No. 333-283023 filed pursuant to rule 485(a) under the Securities Act of
1933, as amended, on November 20, 2025. Parts A, B and C were filed in Amendment No. 2 and are incorporated by reference
herein. Powers of attorney filed
herewith.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it meets all of the requirements for effectiveness of this registration statement under rule 485(b) under the Securities Act and has duly caused this registration statement to be signed on its behalf by the undersigned, duly authorized, in the City of Charlotte, and State of North Carolina, on this 30th day of March, 2026.
| |
By: |
BRIGHTHOUSE LIFE INSURANCE COMPANY |
| |
|
(Insurance Company) |
| |
By: |
/s/
David A. Rosenbaum |
| |
|
David A. Rosenbaum Vice President |
Pursuant to the requirements of
the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated on March 30, 2026.
| /s/ Eric
Steigerwalt* |
Chairman of the Board, President, Chief Executive Officer
and a Director |
| Eric Steigerwalt | |
| |
|
| /s/
Myles Lambert* |
Director |
| Myles Lambert | |
| |
|
| /s/
David A. Rosenbaum* |
Director |
| David A. Rosenbaum | |
| |
|
| /s/
Jonathan Rosenthal* |
Director |
| Jonathan Rosenthal | |
| |
|
| /s/
Edward A. Spehar* |
Director, Vice President and Chief Financial Officer |
| Edward A. Spehar | |
| |
|
| /s/
Melissa B. Pavlovich* |
Vice President and Chief Accounting Officer |
| Melissa B. Pavlovich | |
| |
|
| /s/
Gianna H. Figaro-Sterling* |
Vice President and Controller |
| Gianna H. Figaro-Sterling |
| |
*By: |
/s/
Michele H. Abate |
| |
|
Michele H. Abate, Attorney-In-Fact March 30, 2026 |
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2026
- Early Warning Press Release - Hylton Karon Announces Disposition of Common Shares of iFabric Corp.
- CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share